BB BIOTECH AG

Q1 2019 13F Holdings Report, Stock Holdings

Signature - Title
Ivo Betschart - SIGNING AUTHORITY
Location
Schaffhausen, Switzerland
Holdings as of
31 Mar 2019
Value $
$3,977,857,000
Num holdings
35
Filing time
13 May 2019, 12:49:44 UTC
Form type
13F-HR
Description
All US holdings of this investor are reported in this report. Top holdings included IONS, INCY, NBIX, VRTX, and SAGE.
Previous filing
Q4 2018 - 12 Feb 2019
Sym Weight Trade Impact Company Class Share Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2019 Q1 compared to 2018 Q4 by default. Changes are calculated vs the previous SEC filing.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Ivo Betschart SIGNING AUTHORITY Schaffhausen, Switzerland 09 May 2019

Other Included Managers (4):

Num Name Location File Number
1 BIOTECH FOCUS N. V. Willemstad, Netherlands Antilles 028-11193
2 BIOTECH INVEST N V Willemstad, Netherlands Antilles 028-11191
3 BIOTECH TARGET N V Willemstad, Netherlands Antilles 028-11189
4 BIOTECH GROWTH N V Willemstad, Netherlands Antilles 028-11194